U. Scheipers, S. Siebers, M. Ashfaq, F. Gottwald, A. Bozzato, J. Zenk, H. Iro, H. Ermert
{"title":"Ultrasonic tissue characterization for the differentiation of parotid gland tumors","authors":"U. Scheipers, S. Siebers, M. Ashfaq, F. Gottwald, A. Bozzato, J. Zenk, H. Iro, H. Ermert","doi":"10.1109/ULTSYM.2005.1602977","DOIUrl":null,"url":null,"abstract":"The first ultrasonic tissue characterization system for the computerized differentiation of tumors of the parotid gland is presented. The system is based on a multifeature tissue charac- terization approach involving spectrum and texture parameters and using fuzzy inference systems as higher order classifiers. Baseband ultrasound echo data were acquired during conven- tional ultrasound imaging examinations of the salivary glands. Several tissue-describing parameters were calculated within numerous small regions of interest in order to evaluate local spectral and textural tissue properties. The parameters were pro- cessed by an adaptive network-based fuzzy inference system using the results of conventional histology after parotidectomy as the gold standard. Cases of parotid gland tumors and alterations include basal cell adenomas, monomorphic adenomas, pleomor- phic adenomas, adenoid cysts, cysts and canaliculous adenomas. The results of the classification procedure are presented as a numerical score indicating the probability of a certain tumor or alteration for each parotid gland. In a pilot study, the system was evaluated on 23 cases of benign and malignant parotid gland tumors of patients undergoing parotidectomy. The ROC curve area given as the cross-validation mean and cross-validation standard deviation is AROC=0.95±0.07 when using four-fold cross-validation over cases and differenti- ating between various malignant and benign parotid gland tumors as the positive target group and monomorphic adenomas as the negative target group. An exceptional equal error rate of EEER=0.92±0.08 is achieved for the same setup. Some alterations which are of benign nature were counted to the positive group, as they occur too seldom to achieve a high probability for being considered safe if left untreated.","PeriodicalId":302030,"journal":{"name":"IEEE Ultrasonics Symposium, 2005.","volume":"61 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2005-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Ultrasonics Symposium, 2005.","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ULTSYM.2005.1602977","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
The first ultrasonic tissue characterization system for the computerized differentiation of tumors of the parotid gland is presented. The system is based on a multifeature tissue charac- terization approach involving spectrum and texture parameters and using fuzzy inference systems as higher order classifiers. Baseband ultrasound echo data were acquired during conven- tional ultrasound imaging examinations of the salivary glands. Several tissue-describing parameters were calculated within numerous small regions of interest in order to evaluate local spectral and textural tissue properties. The parameters were pro- cessed by an adaptive network-based fuzzy inference system using the results of conventional histology after parotidectomy as the gold standard. Cases of parotid gland tumors and alterations include basal cell adenomas, monomorphic adenomas, pleomor- phic adenomas, adenoid cysts, cysts and canaliculous adenomas. The results of the classification procedure are presented as a numerical score indicating the probability of a certain tumor or alteration for each parotid gland. In a pilot study, the system was evaluated on 23 cases of benign and malignant parotid gland tumors of patients undergoing parotidectomy. The ROC curve area given as the cross-validation mean and cross-validation standard deviation is AROC=0.95±0.07 when using four-fold cross-validation over cases and differenti- ating between various malignant and benign parotid gland tumors as the positive target group and monomorphic adenomas as the negative target group. An exceptional equal error rate of EEER=0.92±0.08 is achieved for the same setup. Some alterations which are of benign nature were counted to the positive group, as they occur too seldom to achieve a high probability for being considered safe if left untreated.